A patient infected with SARS-Cov-2 presents with DIHS syndrome induced by olanzapine: diagnostic difficulties Cover

.blurhash-client-img { display: none !important; }

A patient infected with SARS-Cov-2 presents with DIHS syndrome induced by olanzapine: diagnostic difficulties

Postępy Higieny i Medycyny Doświadczalnej

Volume 77 (2023): Issue 1 (January 2023)

By: Michalina Pinkosz , Mateusz Szymański and Monika Cendrowska-Pinkosz

Open Access

|Oct 2023

Authors

Michalina Pinkosz

pinkoszmichalina00@gmail.com

Medical University of Lublin: Uniwersytet Medyczny w Lublinie, Lublin, Poland

Mateusz Szymański

Department of Human Anatomy, Medical University of Lublin, Unit of Anaesthesiology and Intensive Therapy, Regional Specialist Hospital, Lublin

Monika Cendrowska-Pinkosz

Department of Human Anatomy, Medical University of Lublin, Lublin, Poland

DOI: https://doi.org/10.2478/ahem-2023-0016 | Journal eISSN: 1732-2693

Journal RSS Feed

Language: English

Page range: 99 - 106

Submitted on: Mar 12, 2023

Accepted on: Aug 10, 2023

Published on: Oct 8, 2023

Published by: Hirszfeld Institute of Immunology and Experimental Therapy

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

drug-induced hypersensitivity syndrome,

drug reaction with eosinophilia and systemic symptoms COVID-19,

Related subjects:

Molecular biology,

Microbiology and virology,

Basic medical science,

© 2023 Michalina Pinkosz, Mateusz Szymański, Monika Cendrowska-Pinkosz, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 77 (2023): Issue 1 (January 2023)Next article